JPRN-UMIN000047390
Not yet recruiting
未知
Multicenter prospective study of Diverticulitis of the colon - Multicenter prospective study of Diverticulitis of the colon
Conditionscolonic diverticulitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- colonic diverticulitis
- Sponsor
- Kawasaki Medical School
- Enrollment
- 300
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients denied colonic diverticulitis by imaging examinations
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Men with Hormone-Refractory Prostate Cancer.EUCTR2006-000341-19-GRAmgen Inc1,700
Active, not recruiting
Not Applicable
Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-refractory Prostate CancerEUCTR2006-000341-19-SEAmgen Inc1,904
Active, not recruiting
Phase 1
A Randomized, Double-Blind, Multicenter Study of Denosumab ComparedWith Zoledronic Acid (Zometa) in the Treatment of Bone Disease inSubjects with Newly Diagnosed Multiple MyelomaEUCTR2010-020454-34-ITAMGEN INC.1,718
Completed
Phase 3
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaBone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate Cancer) and Multiple Myeloma. Cancer (Except Breast and Prostate Cancer) spread to bone and Kahler's disease.1000595910027656NL-OMON30155Amgen Inc.18
Active, not recruiting
Phase 1
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple MyelomaMultiple MyelomaMedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2010-020454-34-GBAmgen Inc1,700